Background Reduced-antigen-content tetanus, diphtheria, and acellular pertussis (Tdap)
vaccine is recommended in many countries for boosting immunity in adolescents and adults …

Objective To assess the effectiveness of reduced acellular pertussis (Tdap) vaccines in
adolescents and adults. Setting Kaiser Permanente Northern California. Design Case …

Safe and effective combination pediatric vaccines are necessary to simplify complex
immunization schedules and to improve coverage and protection for children worldwide. We …

This open, randomised controlled trial studied the immunogenicity and reactogenicity of two
combined low-dose diphtheria, tetanus and acellular pertussis vaccines (Td5aP-IPV …

Boostrix® is a three-pertussis component, combined, reduced-antigen content tetanus,
diphtheria, and acellular pertussis (Tdap) booster vaccine administered as a single …

Vaccination against diphtheria, tetanus, and pertussis (DTP) has achieved great success in
infants and younger children in China. However, pertussis booster vaccination in older …

Availability of combined tetanus-diphtheria-acellular pertussis (Tdap) vaccines for adults
offers a new pertussis prevention strategy for the US. Successful uptake of Tdap vaccine will …

Background. A household contact substudy was performed as part of a prospective, cohort
pertussis vaccine efficacy trial in Germany. Design. Infants received four doses of either the …

A combined DTPa–IPV booster vaccine was administered as a 4th or 5th dose after DTPa or
DTPw priming. Over 99% vaccines developed antibody levels considered to be protective to …

Background Increasing evidence shows that protection induced by acellular pertussis
vaccines is short-lived, requiring repeated booster vaccination to control pertussis disease …